Scarica l'app Stockscreener
1.68
0.00%
0.00
Dopo l'orario di chiusura:
1.68
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GANX Giù?
Forum
Previsione
Precedente Chiudi:
$1.68
Aprire:
$1.68
Volume 24 ore:
134.78K
Relative Volume:
0.47
Capitalizzazione di mercato:
$50.52M
Reddito:
$210.70K
Utile/perdita netta:
$-21.37M
Rapporto P/E:
-1.5273
EPS:
-1.1
Flusso di cassa netto:
$-21.10M
1 W Prestazione:
+4.35%
1M Prestazione:
-6.15%
6M Prestazione:
-23.64%
1 anno Prestazione:
+55.56%
Intervallo 1D:
$1.66
$1.72
Intervallo di 1 settimana:
$1.55
$1.90
Portata 52W:
$0.89
$3.19
Gain Therapeutics Inc Stock (GANX) Company Profile
Nome
Gain Therapeutics Inc
Settore
Industria
Telefono
(301) 500-1556
Indirizzo
4800 HAMPDEN LANE, BETHESDA
Confronta GANX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GANX
Gain Therapeutics Inc
|
1.68 | 56.01M | 210.70K | -21.37M | -21.10M | -1.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Gain Therapeutics Inc Stock (GANX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
| 2024-12-06 | Iniziato | ROTH MKM | Buy |
| 2024-08-14 | Ripresa | Oppenheimer | Outperform |
| 2021-04-12 | Iniziato | BTIG Research | Buy |
| 2021-04-12 | Iniziato | Oppenheimer | Outperform |
Gain Therapeutics Inc Borsa (GANX) Ultime notizie
What makes Gain Therapeutics Inc. stock attractive to long term investorsFree Market Dynamics Reports - jammulinksnews.com
Gain Therapeutics to Present at BTIG Annual Virtual Biotechnology Conference - The Manila Times
Gain Therapeutics to Present at BTIG's Annual Biotechnology Conference. - AInvest
Gain Therapeutics Leadership Team Set for Exclusive Fireside Chat at BTIG Annual Biotech Conference - Stock Titan
Gain Therapeutics Inc. Stock Analysis and ForecastPhenomenal capital gains - Autocar Professional
Is Indaptus Therapeutics Inc. a good long term investmentRapid market gains - jammulinksnews.com
Is Gain Therapeutics Inc. a good long term investmentBreakout portfolio performance - jammulinksnews.com
What analysts say about Gain Therapeutics Inc. stockMarket-leading growth rates - PrintWeekIndia
What drives Gain Therapeutics Inc. stock priceRemarkably fast returns - jammulinksnews.com
What drives Monte Rosa Therapeutics Inc. stock priceExplosive portfolio gains - Autocar Professional
Aardvark Therapeutics Inc. Stock Analysis and ForecastHigh-octane gains - jammulinksnews.com
What drives Allogene Therapeutics Inc. stock priceTremendous gains - jammulinksnews.com
Is Nurix Therapeutics Inc. a good long term investmentSkyrocketing investment returns - Jammu Links News
Analysts Offer Insights on Healthcare Companies: Gain Therapeutics (GANX), Abbott Laboratories (ABT) and ANI Pharmaceuticals (ANIP) - The Globe and Mail
Is Grace Therapeutics Inc. a good long term investmentTremendous gains - jammulinksnews.com
Healthcare Stocks to Watch: Gain Therapeutics, Abbott Laboratories, and ANI Pharmaceuticals - AInvest
Is vTv Therapeutics Inc. a good long term investmentTremendous gains - Jammu Links News
Bicara Therapeutics Inc. Stock Analysis and ForecastHigh-velocity gains - jammulinksnews.com
What drives Mineralys Therapeutics Inc. stock priceHigh-octane gains - Jammu Links News
Is Soleno Therapeutics Inc. a good long term investmentSuperior trading gains - Jammu Links News
What drives Avalo Therapeutics Inc. stock priceExceptional risk-adjusted gains - Jammu Links News
What analysts say about Gain Therapeutics Inc. stock outlookLow Risk High Reward Picks - Newser
Does Avalo Therapeutics Inc. stock pay reliable dividendsReal Time Alert Service - Newser
Is Heron Therapeutics Inc. stock a good hedge against inflationDaily Gain Forecast - Newser
What risks could impact LOGC stock performanceFree Expert-Led Investment Training - Newser
Gain Therapeutics Announces $7 Million Public Offering - TipRanks
Form 424B5 Gain Therapeutics, Inc. - StreetInsider
How Nurix Therapeutics Inc. stock performs during market volatility200 Percent Gain Alert - Newser
Why Gain Therapeutics Inc. stock attracts strong analyst attentionDaily Stock Radar - beatles.ru
Neurodegenerative Biotech's Capital Crunch: The Dilution Dilemma in $7M Offerings - AInvest
Gain Therapeutics Announces Pricing of $7.0 Million Public Offering - The Manila Times
Gain Therapeutics on pricing stock-and-warrants offering - TradingView
Gain Therapeutics Secures $7M Funding to Advance Novel Parkinson's Treatment Pipeline - Stock Titan
US Futures Trade Mixed As June Inflation Ticks Up: ASML, Morgan Stanley, Goldman Sachs, BofA Earnings In Focus - Benzinga
Why Data Storage Shares Are Trading Higher By 35%; Here Are 20 Stocks Moving Premarket - Benzinga
Gain Therapeutics' High-Stakes Gamble: Can GT-02287 Rewrite the Neurodegenerative Treatment Playbook? - AInvest
Gain Therapeutics Plans Public Offering of Common Shares, Warrants - MarketScreener
Gain Therapeutics falls on equity offering plans - TradingView
Gain Therapeutics Announces Proposed Public Offering - The Manila Times
Gain Therapeutics stock falls after announcing public offering By Investing.com - Investing.com Canada
Gain Therapeutics stock falls after announcing public offering - Investing.com
Gain Therapeutics, Inc. Proposes Underwritten Public Offering of Common Stock and Warrants - Nasdaq
Gain Therapeutics Inc Azioni (GANX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):